Potential COVID-19 vaccine shows promise in early trial
02:05Michael Osterholm, an infectious disease expert, reacts to news that a potential COVID-19 vaccine from the drug company Moderna is showing promising results in its Phase 1 trial.
Michael Osterholm, an infectious disease expert, reacts to news that a potential COVID-19 vaccine from the drug company Moderna is showing promising results in its Phase 1 trial.